Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies
Sun T, Wang M, Wang H. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies. Cancer Cytopathology 2022, 130: 964-973. PMID: 35994357, DOI: 10.1002/cncy.22638.Peer-Reviewed Original ResearchConceptsCommunity hospital settingPeritoneal effusionPleural effusionSerous Fluid CytopathologyHospital settingInternal review board approvalReview board approvalPleural fluid specimensUndetermined significanceCommunity hospitalEffusion specimensBoard approvalFluid specimensSerous fluidEffusionOverall ROMMalignancyMalignancy assessmentAUSROM analysisNotable heterogeneityAssociated riskReporting terminologyCytopathologyRiskSignificance of KRAS mutation testing in biliary brushing cytology specimens: A 10‐year retrospective review
Sun T, Zuo T, Hui P, Cai G. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10‐year retrospective review. Cancer Cytopathology 2022, 130: 558-565. PMID: 35417072, DOI: 10.1002/cncy.22579.Peer-Reviewed Original ResearchConceptsExtrahepatic biliary stenosisKRAS mutation testingKRAS mutational analysisKRAS mutationsBiliary stenosisBiliary ductsInstitutional review board approvalResults of cytologyPancreatic duct adenocarcinomaBiliary brushing cytologyReview board approvalCytological diagnostic categoriesRetrospective reviewBiliary stricturesDuct adenocarcinomaAbsolute riskCytology examinationDuct brushingsBiliary brushingsBrushing cytologyMalignant conditionsCytological diagnosisBoard approvalClinical practiceCytology specimens